Publications by authors named "Nicoletta Colombo"

100Publications

Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers.

Gynecol Oncol 2021 Jan 17;160(1):64-70. Epub 2020 Oct 17.

Department of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900 Monza, Italy; Clinic of Obstetrics and Gynecology, San Gerardo Hospital, Via Pergolesi 33, 20900 Monza, Italy.

View Article and Find Full Text PDF
January 2021

Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study.

Eur J Radiol 2020 Feb 13;123:108786. Epub 2019 Dec 13.

Clinica di Radiologia EOC, Istituto di Imaging della Svizzera Italiana (IIMSI), Via Tesserete, 46- 6900, Lugano, Switzerland; Department of Radiology, IEO European Institute of Oncology IRCCS, via Ripamonti 435, 20141 Milan, Italy.

View Article and Find Full Text PDF
February 2020

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.

N Engl J Med 2019 12;381(25):2416-2428

From Centre Léon Bérard (I.R.-C., D.P.), University Claude Bernard Lyon 1 (I.R.-C.), and Centre Hospitalier Lyon-Sud (B.Y.), Lyon, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) (I.R.-C., P.P., F.S., C.L.-P., A.L., P.C., M.R., C.D., B.Y., E.P.-L.), Groupe Hospitalier Diaconesses Croix Saint-Simon (F.S.), Hôpital Européen Georges Pompidou (P.C.), Institut Curie, Hôpital Claudius Régaud (M.R.), and Association de Recherche Cancers Gynécologiques (ARCAGY) (E.P.-L.), Paris, Gustave Roussy, Villejuif (P.P.), Centre Eugène Marquis, Rennes (C.L.-P.), Centre Catherine de Sienne Hôpital Privé du Confluent, Nantes (A.L.), and Institut Curie, Hôpital René Huguenin, Saint Cloud (C.D.) - all in France; the Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples (S.P.), University of Milan-Bicocca and European Institute of Oncology IRCCS, and Mario Negri Gynecologic Oncology Group (MANGO) (N.C.), and Fondazione IRCCS Istituto Nazionale Tumori and MITO (D.L.), Milan, and Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica, and MITO, Rome (G.S.) - all in Italy; M.D. Anderson Cancer Center Madrid (A.G.-M.), Grupo Español de Investigación en Cáncer de Ovario (GEICO) (A.G.-M., E.M.G.A.), and Hospital Universitario Ramón y Cajal (E.M.G.A.) - all in Madrid; Medical University of Innsbruck, University Clinic for Gynecology and Obstetrics (R.B.), and Arbeitsgemeinschaft Gynäkologische Onkologie Study Group (AGO)-Austria (R.B., A.R.), Innsbruck, and Medical University of Vienna, Vienna (A.R.) - all in Austria; Saitama Medical University International Medical Center, Hidaka (K.F.), Gynecologic Oncology Trial and Investigation Consortium (GOTIC), Moroyama-cho (K.F., S.N.), and Hyogo Cancer Center, Akashi (S.N.) - all in Japan; University Hospital Leuven, Leuven Cancer Institute, and Belgium and Luxembourg Gynecologic Oncology Group (BGOG) - both in Leuven, Belgium (I.V.); Tampere University and University Hospital, Tampere, Finland (J.M.); the Nordic Society of Gynecologic Oncology (NSGO), Copenhagen (J.M.); and Charité-Medical University of Berlin (Campus Virchow Klinikum), Berlin (J.S.), German Society of Gynecologic Oncology (AGO) (J.S., U.C., F.M., N.G., P.B., A.B., P.H.), Universitätsklinikum Essen (P.B.), and Kliniken Essen Mitte (P.H.), Essen, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden (U.C.), Universitätsklinikum Heidelberg, Heidelberg (F.M.), Universitätsklinikum Ulm, Ulm (N.G.), and Klinikum der Universität München, Munich (A.B.) - all in Germany.

View Article and Find Full Text PDF
December 2019

Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study.

Lancet Oncol 2019 08 9;20(8):1171-1182. Epub 2019 Jul 9.

Department of Women's Cancer, EGA Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, UK. Electronic address:

View Article and Find Full Text PDF
August 2019

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

N Engl J Med 2018 12 21;379(26):2495-2505. Epub 2018 Oct 21.

From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan-Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica, Rome (G.S.) - both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona (A. Oaknin), and M.D. Anderson Cancer Centre Madrid, Madrid (A.G.-M.) - both in Spain; University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, Australia (M.F.); St. Petersburg City Oncology Dispensary, St. Petersburg, Russia (A. Lisyanskaya); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, Paris (A.F., A. Leary), Institut Bergonié, Comprehensive Cancer Center, Bordeaux (A.F.), and Gustave-Roussy Cancer Campus, Villejuif (A. Leary) - all in France; the Netherlands Cancer Institute, Amsterdam (G.S.S.); Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (C.G.), the Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London (S.B.), and AstraZeneca, Cambridge (R.B.) - all in the United Kingdom; Princess Margaret Cancer Centre, Toronto (A. Oza); Memorial Sloan Kettering Cancer Center, New York (C.A.); Froedtert and the Medical College of Wisconsin, Milwaukee (W.B.); Women and Infants Hospital, Providence, RI (C.M., P.D.); Dana-Farber Cancer Institute, Boston (J.L.); and AstraZeneca, Gaithersburg, MD (E.S.L.).

View Article and Find Full Text PDF
December 2018

Recurrent ovarian cancer 8 months after induction and bevacizumab consolidation: rationale for using trabectedin + pegylated liposomal doxorubicin in second line.

Expert Rev Anticancer Ther 2018 10;18(sup1):13-17

a European Institute of Oncology , University of Milan-Bicocca , Milan , Italy.

View Article and Find Full Text PDF
October 2018

Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday.

Int J Radiat Oncol Biol Phys 2018 07 4;101(3):650-660. Epub 2018 Apr 4.

Department of Radiation Oncology, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

View Article and Find Full Text PDF
July 2018

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.

J Clin Oncol 2018 05 20;36(13):1300-1307. Epub 2018 Mar 20.

Nicoletta Colombo, University of Milan-Bicocca; Nicoletta Colombo, Istituto Europeo di Oncologia, Milan; Giovanni Scambia, Università Cattolica del Sacro Cuore di Roma, Rome; Sandro Pignata, Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G Pascale IRCCS, Naples, Italy; Gloria Huang, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx; Eva Chalas, Winthrop University Hospital, Mineola, NY; James Fiorica, Sarasota Memorial Hospital, Sarasota, FL; Linda Van Le, University of North Carolina School of Medicine, Chapel Hill, NC; Sharad Ghamande, The Georgia Cancer Center at Augusta University, Augusta; Andrew Green, Northeast Georgia Medical Center, Gainesville, GA; Santiago González-Santiago, Hospital San Pedro de Alcántara, Cáceres; Isabel Bover, Hospital Son Llàtzer, Palma; Begoña Graña Suárez, University Hospital A Coruña, Sergas, Spain; Philippe Huot-Marchand and Yann Bourhis, Mapi Real World Evidence, Lyon, France; Sudeep Karve, AstraZeneca, Gaithersburg, MD; and Christopher Blakeley, AstraZeneca, Cambridge, United Kingdom.

View Article and Find Full Text PDF
May 2018

CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.

Stem Cell Reports 2018 04 15;10(4):1412-1425. Epub 2018 Mar 15.

Unit of Gynecological Oncology Research, European Institute of Oncology, Via G. Ripamonti 435, 20141 Milano, Italy. Electronic address:

View Article and Find Full Text PDF
April 2018

Fibroblastic Malignant Peripheral Nerve Sheath Tumour of the Uterine Cervix: Report of a Case and Literature Review With Emphasis on Possible Differential Diagnosis.

Int J Gynecol Pathol 2018 Sep;37(5):497-503

Division of Pathology (V.S.) Division of Gynecology (V.Z., G.A., L.B., S.B., F.L., N.C., A.M., E.R.), European Institute of Oncology, Milan, Italy.

View Article and Find Full Text PDF
September 2018

FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer.

Future Oncol 2018 Jul 9;14(17):1669-1678. Epub 2018 Feb 9.

Division of Hematology-Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL 35294, USA.

View Article and Find Full Text PDF
July 2018

A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis.

Am J Hematol 2018 Feb 17;93(2):E33-E35. Epub 2017 Nov 17.

Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Policlinico San Martino, IRCCS per l'Oncologia, Genoa, Italy.

View Article and Find Full Text PDF
February 2018

When nonplatinum is the answer: the role of trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian cancer.

Future Oncol 2017 Oct 11;13(23s):23-29. Epub 2017 Oct 11.

European Institute of Oncology, University of Milan-Bicocca, via Ripamonti 435, Milan, Italy.

View Article and Find Full Text PDF
October 2017

Clinical benefit and risk of death with endocrine therapy in ovarian cancer: A comprehensive review and meta-analysis.

Gynecol Oncol 2017 09 10;146(3):504-513. Epub 2017 Jul 10.

Division of Medical Oncology E.O. Ospedali Galliera, Genoa, Italy; Wolfson Institute of Preventive Medicine, Queen Mary University of London, United Kingdom. Electronic address:

View Article and Find Full Text PDF
September 2017

Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?

Cancer 2017 Sep 5;123(18):3450-3459. Epub 2017 Jul 5.

Department of Gynecologic Oncology, European Institute of Oncology, Institute for Treatment and Research (IRCCS), Milan, Italy.

View Article and Find Full Text PDF
September 2017

Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future.

Int J Gynecol Cancer 2017 07;27(6):1134-1140

*Division of Gynecologic Oncology, European Institute of Oncology, University of Milan-Bicocca; †Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan; and ‡Department of Gynecology, Cannizzaro Hospital, Catania, Italy.

View Article and Find Full Text PDF
July 2017

Feasibility of Transabdominal Cardiophrenic Lymphnode Dissection in Advanced Ovarian Cancer: Initial Experience at a Tertiary Center.

Int J Gynecol Cancer 2017 07;27(6):1268-1273

*Department of Gynecology, †Department of Radiology, and ‡Division of Gastro-Intestinal Surgery, European Institute of Oncology (IEO), Milan, Italy.

View Article and Find Full Text PDF
July 2017

Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective.

J Clin Oncol 2017 02 9;35(6):587-590. Epub 2017 Jan 9.

Christina Fotopoulou, Imperial College London, London, United Kingdom; Jalid Sehouli, Charité Medical University of Berlin, Berlin, Germany; Giovanni Aletti, European Institute of Oncology, Milan, Italy; Philipp Harter, Kliniken Essen Mitte, Essen, Germany; Sven Mahner, Ludwig-Maximilians-University, Munich, Germany; Denis Querleu, Institut Bergonié, Bordeaux, France; Luis Chiva, Clínica Universidad de Navarra, Navarra, Spain; Hani Gabra, Imperial College London, London, United Kingdom; Nicoletta Colombo, European Institute of Oncology, Milan, Italy; and Andreas du Bois, Kliniken Essen Mitte, Essen, Germany.

View Article and Find Full Text PDF
February 2017

Experience with trabectedin + pegylated liposomal doxorubicin for recurrent platinum-sensitive ovarian cancer unsuited to platinum rechallenge.

Expert Rev Anticancer Ther 2016 Nov;16(sup1):11-19

e Clinical Area of Gynecological Cancer , Fundación Instituto Valenciano de Oncología , Valencia , Spain.

View Article and Find Full Text PDF
November 2016

Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study.

Int J Gynecol Cancer 2017 01;27(1):50-58

*Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada; †Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, and Alliance Pour la Recherche en Cancérologie, Paris, France; ‡Chemotherapy Department of State Budgetary Healthcare Institution, Clinical Oncology Dispensary #1, Krasnodar Region Ministry of Healthcare, Krasnodar, Russia; §Gynecologic Oncology Department, Sheba Medical Center, Tel Hashomer, Israel; ∥University Hospital 12 de Octubre, Madrid, Spain; ¶Medical Department, Gustave Roussy, Villejuif, France; #Department of Clinical Oncology, Oncology Center Prof. F. Lukaszczyka, Bydgoszcz, Poland; **Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece; ††Ente Ospedaliero Ospedali Galliera, Genoa, Italy; ‡‡Riga East University Hospital, Latvian Oncology Centre, Riga, Latvia; §§Medical Oncology Department, MD Anderson Cancer Center Madrid, Madrid, Spain; ∥∥Pérola Byington Hospital/Faculty of Medicine University of São Paulo, São Paulo, Brazil; ¶¶Medical Oncology Department, Centre François Baclesse, Caen, France; ##Policlinico Sant'Orsola-Malpighi, Bologna, Italy; ***Division of Gynecology and Obstetrics, Department of Experimental and Clinical Medicine, University of Pisa, Pisa, Italy; †††Global Medical Affairs, F. Hoffmann-La Roche Ltd, Basel, Switzerland; and ‡‡‡Division of Medical Gynecologic Oncology, European Institute of Oncology and University of Milano-Bicocca, Milan, Italy.

View Article and Find Full Text PDF
January 2017

Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).

J Clin Oncol 2016 07 6;34(21):2516-25. Epub 2016 Jun 6.

Christian Kurzeder and Andreas du Bois, Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Kliniken Essen Mitte, Essen; Frederik Marmé, AGO and University Hospital Heidelberg, Heidelberg; Joern Rau and Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg; Sven Mahner, AGO and University Medical Center Hamburg-Eppendorf, Hamburg; Sandra Polleis, AGO Study Group, Wiesbaden, Germany; Isabel Bover, Grupo Español de Investigación en Cáncer de Ovario (GEICO) and Hospital Son Llàtzer, Palma de Mallorca; Pilar Barretina-Ginesta, GEICO and Catalan Institute of Oncology, Girona; Josep M. del Campo, GEICO and Vall d'Hebron University Hospital, Barcelona; Antonio Gonzalez-Martin, GEICO and MD Anderson Cancer Center Spain, Madrid, Spain; Patricia Pautier, Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Institut Gustave Roussy, Villejuif; Anne Floquet, GINECO and Institut Bergonié, Bordeaux, France; Nicoletta Colombo, Mario Negri Gynecologic Oncology Group and University of Milan Bicocca-European Institute of Oncology; Domenica Lorusso, Multicenter Italian Trials in Ovarian Cancer and Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, National Cancer Institute, Milan, Italy; Petronella Ottevanger, Dutch Gynecological Oncology Group and Radboud University Medical Center, Nijmegen, the Netherlands; Maria Bjurberg, Nordic Society of Gynecological Oncology and Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden; Christian Marth, AGO-Austria and Innsbruck Medical University, Innsbruck, Austria; Ignace Vergote, AGO and University Hospital Leuven, Leuven, Belgium; and Lydie Bastière-Truchot, Nicolas Martin, Mikkel Z. Oestergaard, and Astrid Kiermaier, F. Hoffmann-La Roche, Basel, Switzerland.

View Article and Find Full Text PDF
July 2016

Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial.

Int J Gynecol Cancer 2016 06;26(5):898-905

* and Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain; †GINECO and Medical Oncology Department, Institut Gustave Roussy, Villejuif, France; ‡AGO and Department of Gynaecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; §Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany; ∥MaNGO and Division of Medical Gynecologic Oncology, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy; ¶DGOG and Department of MedicalOncology, Radboud University Medical Center, Nijmegen, The Netherlands; #GEICO and Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; **GINECO and Tenon Hospital AP-HP and Alliance Pour la Recherche en Cancérologie, France; ††AGO and Department of Gynecology and GynecologicOncology, Kliniken Essen Mitte, Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany; ‡‡MaNGO and Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy; §§GEICO and Medical Oncology Department, Parc Taulí Sabadell-Hospital Universitari, Sabadell, Spain; ∥∥GINECO and Medical Oncology Department, Integrated Center for Oncology Nantes-Angers, Nantes, France; ¶¶AGO and National Centre for Tumour Diseases, Division of Gynaecologic Oncology, University Hospital Heidelberg, Heidelberg, Germany; ##GEICO and Department of Medical Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain; ***Global Medical Affairs Biometrics, and †††Global Medical Affairs, F. Hoffmann-La Roche Ltd; and ‡‡‡Oncology Biomarker Development at Genentech Early Research and Development, Basel, Switzerland.

View Article and Find Full Text PDF
June 2016

Fertility-Sparing Options in Young Women with Cervical Cancer.

Curr Treat Options Oncol 2016 Jan;17(1)

European Institute of Oncology "IEO,", Via Giuseppe Ripamonti 435, 20141, Milan, Italy.

View Article and Find Full Text PDF
January 2016

Optimising the treatment of the partially platinum-sensitive relapsed ovarian cancer patient.

EJC Suppl 2014 Dec 13;12(2):7-12. Epub 2015 Jan 13.

Institute of Oncology and University of Milan-Bicocca, Milan, Italy.

View Article and Find Full Text PDF
December 2014

ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up.

Radiother Oncol 2015 Dec 9;117(3):559-81. Epub 2015 Dec 9.

Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.

View Article and Find Full Text PDF
December 2015

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.

Int J Gynecol Cancer 2016 Jan;26(1):2-30

*Division of Medical Gynecologic Oncology, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy; †Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands; ‡Department of Gynecological Oncology, University Hospital Leuven, Leuven, Belgium and Center for Gynecological Oncology Amsterdam (CGOA), Antoni van Leeuwenhoek, Amsterdam, The Netherlands; §Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; ∥Medical Oncology Department, GEICO and MD Anderson Cancer Center, Madrid, Spain; ¶Department of Oncology and Cancer Trials, UCL Cancer Institute, London, United Kingdom; #Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria; **Department of Radiotherapy, Leiden University Medical Center, Leiden, The Netherlands; ††Department of Surgery, Institut Bergonié, Bordeaux, France and Gynecology and Obstetrics Department, McGill University Health Centre, Montreal, Quebec, Canada; ‡‡Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; and §§Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.

View Article and Find Full Text PDF
January 2016

Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma.

Biomed Res Int 2015 22;2015:943096. Epub 2015 Oct 22.

Hematology Unit, Department of Internal Medicine (DiMI), University of Genoa, IRCCS AOU San Martino-IST, 1600 Genoa, Italy.

View Article and Find Full Text PDF
August 2016

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer.

Ecancermedicalscience 2015 22;9:584. Epub 2015 Oct 22.

Academic Division of Gynaecology and Obstetrics, Mauriziano Hospital, University of Turin, Italy.

View Article and Find Full Text PDF
November 2015

Bevacizumab in ovarian cancer: Focus on clinical data and future perspectives.

Crit Rev Oncol Hematol 2016 Jan 10;97:335-48. Epub 2015 Aug 10.

Policlinico Universitario A. Gemelli, Rome, Italy. Electronic address:

View Article and Find Full Text PDF
January 2016

Neoadjuvant chemotherapy in cervical cancer: an update.

Expert Rev Anticancer Ther 2015 7;15(10):1171-81. Epub 2015 Sep 7.

b 2 Department of Gynaecology and Obstetrics, University Campus Bio Medico, Rome, Italy.

View Article and Find Full Text PDF
May 2016

Special issues in fertility preservation for gynecologic malignancies.

Crit Rev Oncol Hematol 2016 Jan 8;97:206-19. Epub 2015 Sep 8.

European Institute of Oncology "IEO", Via Giuseppe Ripamonti 435, 20141 Milan, Italy.

View Article and Find Full Text PDF
January 2016

Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines.

Authors:
M Kloke N Cherny

Ann Oncol 2015 Sep;26 Suppl 5:v169-73

Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.

View Article and Find Full Text PDF
September 2015